Modified drug combination may reduce risk of recurrence for some breast cancer patients
Oncologists at VCU Massey Cancer Center were invited to co-author an editorial published in the Journal of Clinical Oncologyproviding expert commentary on findings from a large study conducted by German investigators that a modified drug combination may lead to a decreased chance of disease recurrence for women with high risk, HER-2 negative breast cancer.
Source: Medical Xpress
Leave a Reply